genprowebdirectory
GEN Edge
Latest News
Login
Subscribe
News
Insights
Trends for 2020
Trends for 2021
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Privacy Policy
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Latest News
Login
Subscribe
News
Cell Signaling
Overlooked Covalent Crosslink an On/Off Switch for Proteins
Antibacterials
Discovery That Antibiotic “Pops” Bacteria Could Lead to Improved Treatments for…
Neurological Disorders
NSAIDs May Improve Reduced Cognition upon Short-term Exposure to Air Pollution…
Biomarkers
Improving Sequencing Errors and Detection of Rare Mutations
3D Cell Culture
Brain Organoids Might Lead to Neurological Disease Therapies
Insights
All
Trends for 2020
Trends for 2021
Bioprocessing
Raising Awareness of 4.0 in Biomanufacturing—Part II
Bioprocessing
Avrobio Keeps Its Platform Closed and Compact
Bioprocessing
Solving Contract Manufacturing Shortages by Going In-House
Biomarkers
Biopharma’s Resilience to Future Pandemics Relies on Manufacturing Innovation
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
A-Lists
Top 10 Life Sciences Jobs Most in Demand over the Next…
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020
A-Lists
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Companies
Novartis
Novartis
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Novartis
Novartis, Artios Pharma Target Cancer in Up-to-$1.3B DDR Collaboration
Novartis
Sangamo CEO Ponders Pipeline, Reflects on Phase III ‘Proud Moment’
Novartis
A New Vision for Gene Therapy
Novartis
Novartis Taps Sangamo Zinc Finger Tech for Gene Regulation Therapies
Novartis
Dyno Inks Up to $2B+ in Gene Therapy Partnerships with Novartis, Sarepta
Novartis
Novartis Plans Phase III Trial of Hydroxychloroquine for COVID-19
Novartis
FDA Places Partial Clinical Hold on Some Trials of Novartis Gene...
Novartis
MorphoSys, Galapagos Halt Development of Atopic Dermatitis Candidate Licensed to Novartis
Novartis
Novartis, Microsoft Launch AI Collaboration
Novartis
Novartis Gains Option to Acquire Second IFM Subsidiary in Up-to-$840M cGAS/STING...
Novartis
Gilead Grows Antiviral Pipeline with Novartis, DURECT Licensing Deals
Novartis
AveXis Turns to Catalent’s Paragon for Additional Gene Therapy Manufacturing Capacity
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
